ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,191.29
0.60%
Dow Jones
38,834.86
0.15%
Gold vs US Dollar
2,329.135
0.38%
Brent Oil
84.86
0.09%
Bitcoin
65,047.12
-0.14%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. ETFs
  4. USA
  5. AMEX
  6. Meet Kevin Pricing Power ETF (PP)

  7. Meet Kevin Pricing Power ETF (PP) News

Meet Kevin Pricing Power... (PP)

Meet Kevin Pricing Power ETF
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:PP
DateTimeSourceHeadlineSymbolCompany
09/10/200818:03Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)AMEX:PPMeet Kevin Pricing Power ETF
06/10/200813:30MarketwiredPipex Pharmaceuticals to Present at the Maxim Group Growth Conference on October 7thAMEX:PPMeet Kevin Pricing Power ETF
19/09/200813:30MarketwiredPipex Pharmaceuticals' Oral TRIMESTA Phase IIa Clinical and Preclinical Findings Presented at World Congress on Treatment and ReAMEX:PPMeet Kevin Pricing Power ETF
29/08/200822:01Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Amended Annual Report (Small Business Issuers) (10KSB/A)AMEX:PPMeet Kevin Pricing Power ETF
19/08/200813:54MarketwiredPipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate for Rheumatoid ArthritisAMEX:PPMeet Kevin Pricing Power ETF
19/08/200813:30MarketwiredPipex Pharmaceuticals, Inc. to Present at the RedChip Small Cap Investor Conference in New York CityAMEX:PPMeet Kevin Pricing Power ETF
14/08/200821:49Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Quarterly Report (10-Q)AMEX:PPMeet Kevin Pricing Power ETF
14/08/200821:18Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
14/08/200818:39MarketwiredPipex Pharmaceuticals Announces Clinical Update and Second Quarter 2008 ResultsAMEX:PPMeet Kevin Pricing Power ETF
12/08/200813:27MarketwiredPipex Pharmaceuticals to Present at the Noble Financial Equity ConferenceAMEX:PPMeet Kevin Pricing Power ETF
15/07/200813:40Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:PPMeet Kevin Pricing Power ETF
14/07/200823:45Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4)AMEX:PPMeet Kevin Pricing Power ETF
09/07/200819:48Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
09/07/200813:38MarketwiredPipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of OrAMEX:PPMeet Kevin Pricing Power ETF
08/07/200822:16Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
08/07/200820:54MarketwiredPipex Pharmaceuticals to Host Conference Call at 10:15am ET Wednesday July 9th to Discuss Phase II Clinical Trial Results in DryAMEX:PPMeet Kevin Pricing Power ETF
08/07/200812:41MarketwiredPipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive OfficerAMEX:PPMeet Kevin Pricing Power ETF
20/05/200814:00MarketwiredPipex Pharmaceuticals Announces Issuance of Additional US Patent Covering CD4 Inhibitor MoleculesAMEX:PPMeet Kevin Pricing Power ETF
16/05/200815:59Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
15/05/200822:13Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Quarterly Report (10-Q)AMEX:PPMeet Kevin Pricing Power ETF
15/05/200821:36MarketwiredPipex Pharmaceuticals Announces Clinical Update and First Quarter 2008 ResultsAMEX:PPMeet Kevin Pricing Power ETF
13/05/200814:05MarketwiredPipex Pharmaceuticals to Provide Clinical Update and Report First Quarter 2008 Results on Thursday, May 15AMEX:PPMeet Kevin Pricing Power ETF
12/05/200814:23MarketwiredPipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for Idiopathic Pulmonary Fibrosis (IPF)AMEX:PPMeet Kevin Pricing Power ETF
07/05/200814:00MarketwiredPipex Pharmaceuticals Announces Notice of Allowance of U.S. Patent for Oral TTM for Alzheimer's DiseaseAMEX:PPMeet Kevin Pricing Power ETF
02/05/200813:38Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
29/04/200820:35Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Proxy Statement (definitive) (DEF 14A)AMEX:PPMeet Kevin Pricing Power ETF
21/04/200813:02MarketwiredPipex Pharmaceuticals' Oral Flupirtine Receives IND With FDA for Phase II Clinical Trial for FibromyalgiaAMEX:PPMeet Kevin Pricing Power ETF
18/04/200822:13Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)AMEX:PPMeet Kevin Pricing Power ETF
15/04/200816:12Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4)AMEX:PPMeet Kevin Pricing Power ETF
01/04/200818:49Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
 Showing the most relevant articles for your search:AMEX:PP

Your Recent History

LSE
BIRD
Blackbird
LSE
GDP
Goldplat
LSE
PHNX
Phoenix
LSE
PANR
Pantheon Resources
LSE
ENET
Ethernity Networks
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved